Verma S, Goldenberg RM, Bhatt DL, Farkouh ME, Quan A, Teoh H, Connelly KA, Leiter LA, Friedrich JO
While studies have primarily only looked at SGLT-2 in kidney transplant patients, we can hypothesize comparable results among liver transplant recipients
Novo Nordisk said patent expiry was a natural part of the pharmaceutical product lifestyle and the company was exploring new molecules, combinations and formulations of treatments, both organically and through external opportunities
Gallbladder Issues Research shows an increase in gallbladder-related issues in GLP-1 medication users, with conditions ranging from asymptomatic gallstones to severe cholecystitis requiring surgical intervention
Reports and Surveys | January 22, 2026 We conducted a cost-benefit analysis of glucagon-like peptide-1 agonists (GLP-1s) using data from SHAPE, our proprietary health data warehouse
Higher body mass index (BMI) is associated with increased mortality risk compared to normal weight (BMI 18.5-25 kg/m)